Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits
Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits
About this item
Full title
Author / Creator
Publisher
New Zealand: Taylor & Francis Ltd
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Taylor & Francis Ltd
Subjects
More information
Scope and Contents
Contents
To describe the pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits.
The right eye of 20 rabbits was injected intravitreally with 1.25 mg/0.05 mL bevacizumab. Both eyes of four rabbits each time were enucleated at days 1, 3, 8, 15, and 29. Bevacizumab concentrations were measured in serum, aqueous humor, and vitreous.
Maximum v...
Alternative Titles
Full title
Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_af53d795422f483f931ce5320837b88f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_af53d795422f483f931ce5320837b88f
Other Identifiers
ISSN
1177-5483,1177-5467
E-ISSN
1177-5483
DOI
10.2147/OPTH.S19555
